Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome

• Autores principales: Saritha Ranabothu (Autor), Clare C. Brown (Autor), Richard Blaszak (Autor), Rachel Millner (Autor), Kristen Rice Moore (Autor), Parthak Prodhan (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Hemolytic uremic syndrome (HUS) is a complex disease with multi-organ involvement. Eculizumab therapy is recommended for treatment of complement mediated hemolytic uremic syndrome (cHUS). However, there are few studies evaluating eculizumab therapy among children with HUS. The primary ob...